Spanish Red Biotech Pipeline

MSD

Pembrolizumab/Olaparib

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: Olaparib in Combination with Pembrolizumab in Participants with Previously Treated, Homologous Recombination Repair Mutation (HRRm) and/or Homologous Recombination Deficiency (HRD)-Positive Advanced Cancer
Phase: 2Phase II in Spain, 1Phase I